CXCL8 and ovarian cancer: Consequently, using either DEX to inhibit IL-8 gene expression in CRPC cells or the IL-8 gene-silencing strategy in ovarian cancer cells (Merritt et al, 2008) indicates that IL-8 signalling does not modulate the mechanistic basis of taxane-induced cell death in tumour cells.